Thomas F Imperiale MD
Professor, Medicine, Indiana University School of Medicine
Join to View Full Profile
550 University Blvd# UH4100Indianapolis, IN 46202
Phone+1 317-944-8660
Fax+1 812-933-3729
Dr. Imperiale is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
The MetroHealth System/Case Western Reserve UniversityFellowship, Gastroenterology, 1992 - 1994
Yale-New Haven Medical CenterResidency, Internal Medicine, 1985 - 1987
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1981 - 1984
New York University School of MedicineClass of 1981
Certifications & Licensure
IN State Medical License 1996 - 2025
OH State Medical License 1984 - 2000
PA State Medical License 2000 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellow (AGAF) American Gastroenterological Association, 2009
- Fellow (FACP) American College of Physicians, 1995
Clinical Trials
- Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Start of enrollment: 2012 Apr 30
- A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval Start of enrollment: 2015 Apr 01
- Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C" Start of enrollment: 2019 Nov 15
- Join now to see all
Publications & Presentations
PubMed
- Effect of the COVID-19 pandemic on colorectal cancer screening in two university-affiliated health care systems.Vinod Kumar, Lilian Golzarri-Arroyo, Sarah Roth, Thomas F Imperiale
Plos One. 2025-01-01 - Impact of the COVID-19 pandemic on adherence to diagnostic colonoscopy after a positive non-invasive screening test for colorectal cancer in two Indiana healthcare sys...Benjamin Richter, Sarah M Roth, Lilian Golzarri-Arroyo, Vinod Kumar, Rick Tuason
Preventive Medicine Reports. 2025-01-01 - Multitarget Stool RNA Testing.Thomas F Imperiale, Philip Lavin, David F Ransohoff
JAMA. 2024-04-23
Journal Articles
- Thinking Big About Small Adenomas: Moving Towards “Precision Surveillance”Thomas Imperiale, MD, Nature
Press Mentions
Exploring Impact of the COVID-19 Pandemic on Colorectal Cancer Screening, DiagnosisApril 3rd, 2025- HMN 2025: How to Explore the COVID-19 Pandemic’s Affect on Colorectal Cancer Screening and AnalysisMarch 29th, 2025
- Exploring the COVID-19 Pandemic's Impact on Colorectal Cancer Screening and DiagnosisMarch 26th, 2025
- Join now to see all
Grant Support
- Implementing evidence based colorectal cancer screening in rural clinicsINDIANA UNIVERSITY INDIANAPOLIS2023–2027
- Neoplastic Yield Of Colonoscopy In The VA Health Care SystemVeterans Affairs2011
- Neoplastic Yield Of Colonoscopy In The VA Health Care SystemHealth Services Research &Development2009
- Quantifying Risk To Target Screening ColonoscopyNational Cancer Institute2004–2009
- Using Risk To Tailor Management Of Digestive DiseasesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Risk Stratification For Prevalent Digestive DiseasesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
